Human Recombinant Leptin Administration as a Potential Obesity Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-6115|10|2|50-54

ISSN： 1871-5222

Source： Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol.10, Iss.2, 2010-06, pp. : 50-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human Recombinant Antibody to HSP90: A Natural Partner in Combination Therapy

By  

Current Molecular Medicine, Vol. 5, Iss. 4, 2005-06 ,pp. : 403-411

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of Obesity Drug Therapy

By  

Current Molecular Medicine, Vol. 14, Iss. 7, 2014-08 ,pp. : 891-908

Bentham Science Publishers

Access to resources Recommend Favorite

Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation

By Baron F.   Sautois B.   Baudoux E.   Matus G.   Fillet G.   Beguin Y.  

Experimental Hematology, Vol. 30, Iss. 6, 2002-06 ,pp. : 546-554

Elsevier

Access to resources Recommend Favorite

Changes in cyclosporine A levels in pediatric renal allograft recipients receiving recombinant human growth hormone therapy

By Sanchez C.P.   Salem M.   Ettenger R.B.  

Transplantation Proceedings, Vol. 32, Iss. 8, 2000-12 ,pp. : 2807-2810

Elsevier

Access to resources Recommend Favorite

Inositol Phosphoglycans and the Regulation of the Secretion of Leptin: In Vitro Effects on Leptin Release from Adipocytes and the Relationship to Obesity

By Kunjara S.   Wang D.Y.   McLean P.   Greenbaum A.L.   Rademacher T.W.  

Molecular Genetics and Metabolism, Vol. 70, Iss. 1, 2000-05 ,pp. : 61-68

Academic Press

Access to resources Recommend Favorite